Stay updated with breaking news from Nasdaq Bcda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioCardia (NASDAQ:BCDA – Get Rating) announced its quarterly earnings results on Tuesday. The company reported ($0.20) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.01, Fidelity Earnings reports. BioCardia had a negative return on equity of 72.74% and a negative net margin of 1,237.37%. During the same period in the […]
BioCardia (NASDAQ:BCDA – Get Rating) and Ablynx (OTCMKTS:ABLYF – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings. Analyst Ratings This is a summary of recent ratings and price targets […]
BioCardia, Inc. (NASDAQ:BCDA – Get Rating) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 1,080,000 shares, an increase of 425.3% from the January 31st total of 205,600 shares. Based on an average daily volume of 1,390,000 shares, the days-to-cover ratio is currently […]
BioCardia to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference March 15, 2021 08:00 ET | Source: BioCardia, Inc. BioCardia, Inc. San Carlos, California, UNITED STATES SAN CARLOS, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, announces that CEO Dr. Peter Altman will present at Maxim Group’s Investors can view Dr. Altman’s live fireside chat presentation at 3:30pm ET on March 19 and once regist...